Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:28 PM
Ignite Modification Date:
2025-12-24 @ 5:28 PM
NCT ID:
NCT01893268
Eligibility Criteria:
Inclusion Criteria:
* Adult patients, \>= 65 years of age
* Diagnosis of advanced non squamous Non-Small Cell Lung Carcinoma (nsNSCLC, stage IIIB or IV) for whom the physician has decided to initiate a treatment with Avastin combined with chemotherapy as 1st line therapy
* Having received oral and written information about the study, and having signed a written consent form
Exclusion Criteria:
* Participation in a cancer clinical trial with an investigational medicinal product other than this study
* Patient previously treated with Avastin
* Patient under supervision or guardianship
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT01893268
Study Brief:
Protocol Section:
NCT01893268